AI assistant
Hester Biosciences Ltd Call Transcript 2018
62222_rns_2018-10-24_736e0268-798a-42ad-9926-f8ec9d6c4c0d.pdf
Call Transcript
Open in viewerOpens in your device viewer
24 October 2018
To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
To, National Stock Exchange of India Limited Exchange Plaza, Bandra – Kurla Complex, Bandra (E), Mumbai - 400 051
Scrip Code: 524669
Symbol: HESTERBIO
Respected Sir / Madam,
Subject: Intimation of earnings conference call to be held on 29 October 2018
This is to inform you that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Monday, 29 October 2018 at 2.00 pm. to discuss the Standalone Unaudited Financial Results for the quarter and half year ended on 30 September 2018.
You are requested to take the above on record.
Sincerely, For Hester Biosciences Limited
Rajiv Gandhi CEO & Managing Director DIN: 00438037
Hester Biosciences
Earnings Conference Call
Monday, 29th October 2018 2:00 pm (IST)
IIFL is pleased to invite you to join a conference call with the management of Hester Biosciences to discuss the company's business strategy and outlook post the declaration of its Q2/H1 FY19 financial results.
| Management participants | Mr. Rajiv Gandhi –CEO & Managing DirectorMr. Jigar Shah –Chief Financial Officer |
|---|---|
| Date / Time | 29th October 2018 (Monday) –2:00 pm IST(HK/Singapore –04:30 pm, UK –09:30 am, USA –04:30 am ET) |
| Conference dial-in numbers | |
| India | |
| Primary Number | +91 22 6280 1259 / +91 22 7115 8160 |
| Local Access Number | +91 704 567 1221 |
| International | Toll-free number |
| USA | 1-866 746 2133 |
| USA (Los Angeles) | 1-323 386 8721 |
| UK | 0-808 101 1573 |
| Singapore | 800-101 2045 / 65-3157 5746 |
| Hong Kong | 800-964 448/ 852-3018 6877 |
For further information, please contact:
Dr. Abhishek Sharma | Tel: +91 22 4646 4668 | Email: [email protected]